Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

South African HIV-1 vaccine candidates - the journey from the bench to clinical trials.

Williamson AL, Rybiki E, Shephard E, Gray G, Bekker LG, Downing K, Williamson C.

S Afr Med J. 2012 Mar 2;102(6):452-5.

PMID:
22668934
2.
4.
5.

HIV vaccines in infants and children.

Lambert JS.

Paediatr Drugs. 2005;7(5):267-76. Review.

PMID:
16220994
6.

HIV vaccines: a global perspective.

Esparza J, Osmanov S.

Curr Mol Med. 2003 May;3(3):183-93. Review.

PMID:
12699356
8.

HIV vaccine development: past, present and future.

Robb ML.

IDrugs. 2010 Dec;13(12):852-6. Review.

PMID:
21154142
9.

A review of vaccine research and development: the human immunodeficiency virus (HIV).

Girard MP, Osmanov SK, Kieny MP.

Vaccine. 2006 May 8;24(19):4062-81. Epub 2006 Feb 28. Review.

PMID:
16530298
10.

HIV: The next shot.

Check Hayden E.

Nature. 2008 Jul 31;454(7204):565-9. doi: 10.1038/454565a. No abstract available.

PMID:
18668076
11.

The past, present and future of HIV-vaccine development: a critical view.

Bojak A, Deml L, Wagner R.

Drug Discov Today. 2002 Jan 1;7(1):36-46. Review.

PMID:
11790602
12.

Building collaborative networks for HIV/AIDS vaccine development: the AVIP experience.

Ferrantelli F, Buttò S, Cafaro A, Wahren B, Ensoli B.

Springer Semin Immunopathol. 2006 Nov;28(3):289-301. Epub 2006 Sep 16. Review.

PMID:
16983452
13.

The expanding vaccine development pipeline, 1995-2008.

Davis MM, Butchart AT, Coleman MS, Singer DC, Wheeler JR, Pok A, Freed GL.

Vaccine. 2010 Feb 3;28(5):1353-6. doi: 10.1016/j.vaccine.2009.11.007. Epub 2009 Nov 21. Review.

PMID:
19932670
14.

Challenges to conducting HIV preventative vaccine trials with adolescents.

McClure CA, Gray G, Rybczyk GK, Wright PF.

J Acquir Immune Defic Syndr. 2004 Jun 1;36(2):726-33. Review.

PMID:
15167292
15.

The development of HIV-1 subtype C vaccines for Southern Africa.

Williamson AL.

IUBMB Life. 2002 Apr-May;53(4-5):207-8. Review.

16.

A brief history of the global effort to develop a preventive HIV vaccine.

Esparza J.

Vaccine. 2013 Aug 2;31(35):3502-18. doi: 10.1016/j.vaccine.2013.05.018. Epub 2013 May 21. Review.

17.

Antituberculous vaccine development: a perspective for the endemic world.

Verma I, Grover A.

Expert Rev Vaccines. 2009 Nov;8(11):1547-53. doi: 10.1586/erv.09.111. Review.

PMID:
19863247
18.

30 years of AIDS vaccine research.

[No authors listed]

IAVI Rep. 2011 May-Jun;15(3):9-12. No abstract available.

19.

[Designing an effective AIDS vaccine: strategies and current status].

Coutsinos Z, Absi Z, Henin Y, Guillet JG, Launay O.

Rev Med Interne. 2008 Aug;29(8):632-41. doi: 10.1016/j.revmed.2007.12.006. Epub 2008 Feb 6. Review. French.

PMID:
18258341
20.

Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how?

Esparza J, Bhamarapravati N.

Lancet. 2000 Jun 10;355(9220):2061-6. Review.

PMID:
10885368
Items per page

Supplemental Content

Write to the Help Desk